United States· US:70121-1744_9f368bb0-0e5d-47f4-9d56-a838da0a7eba
Foscarnet Sodium
A foscarnet product containing foscarnet sodium, registered in United States by Amneal Pharmaceuticals LLC. The same ATC class is registered in 12 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Foscarnet is registered in 12 of 19 countries.
Countries holding a registration under ATC J05AD01 (foscarnet), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 7 of them publish a price we can compare per daily dose
Foscarnet · ATC J05AD01
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- FOSCARNET SODIUM
- Manufacturer
- Amneal Pharmaceuticals LLC
- Country
- United States (US)
- ATC code
- J05AD01
- ATC class
- Foscarnet
- Defined daily dose
- 6.5 g, P
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1170121-1744-2
- ndc1170121-1744-7
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
245 interactions on record for foscarnet.
Graded by severity as the source publishes them — 70 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Foscarnet · interactions on record
245 records
- 70 severe
- 157 moderate
- 2 minor
- 16 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- NeomycinA07AA01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Foscarnet in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- GermanyFoscarnet KabiFresenius Kabi Deutschland Gmbh
- FranceFOSCARNET KABI 24 mg/ml, solution pour perfusionFRESENIUS KABI FRANCE
- SpainFOSCARNET KABI 24 MG/ML SOLUCION PARA PERFUSION EFGFresenius Kabi España, S.A.U.
- FinlandFoscarnet TillomedTillomed Pharma GmbH
- United KingdomFoscarnet sodium 6g/250ml solution for infusion bottlesTillomed Laboratories Ltd
- NorwayFoskarnetnatriumheksahydrat TillomedTillomed Pharma GmbH - Schönefeld
- BelgiumFoscarnet Fresenius Kabi 24 mg/mlFresenius Kabi
- SwedenFoscarnet Tillomed 24 mg/ml Infusionsvätska, lösningTillomed Pharma GmbH
Authorised across Europe · EMA
The same active substance is authorised in 24 EEA countries. Names it is sold under:
- Austria · Foscarnet Tillomed
- Belgium · Foscarnet Fresenius Kabi, Foscavir
- Czechia · Foscarnet Tillomed
- Germany · Foscarnet Kabi, Foscarnet Tillomed
- Denmark · Foscarnet Tillomed, Virafosc
- Estonia · Foscarnet Sodium Tillomed
- Spain · Foscarnet Kabi, Foscarnet Tillomed
- Finland · Foscarnet Tillomed, Virafosc
- France · Foscarnet Kabi, Foscarnet Medipha
- United Kingdom (Northern Ireland) · Foscarnet Sodium Fresenius Kabi Ltd, Foscarnet Sodium Tillomed
- Greece · Foscarnet Tillomed
- Hungary · Foscavir
- Ireland · Foscarnet Sodium Hexahydrate Tillomed
- Italy · Foscarnet Kabi, Foscarnet Tillomed
- Lithuania · Foscarnet Sodium Hexahydrate Tillomed
- Luxembourg · Foscavir
- Latvia · Foscarnet Sodium Tillomed
- Malta · Foscarnet Kabi
- Netherlands · Foscarnet Tillomed, Foscavir
- Norway · Foskarnetnatriumheksahydrat Tillomed, Virafosc
- Poland · Foscarnet Tillomed
- Portugal · Foscarneto Sódico Kabi, Foscarneto Sódico Tillomed
- Sweden · Foscarnet Tillomed, Virafosc
- Slovakia · Foscarnet Tillomed
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/afdc43cc-bcbb-458b-badf-03b6147771a6 GET /v1/drugs/afdc43cc-bcbb-458b-badf-03b6147771a6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "24",
"substance": "FOSCARNET SODIUM",
"productndc": "70121-1744",
"dosage_form": "INJECTION",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "ANDA216602",
"marketing_category": "ANDA"
}See everything about foscarnet.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.